Faculty profile
Daniel Keir
Back to facultyResearch
Read how they describe their research on their Western University profile.
Latest funding
- $929,475
The use of semaglutide and resistance exercise to combat cognitive decline in older adults with Type 2 Diabetes: A combined pharmacological and lifestyle intervention
CIHR · 2024 · Co-investigator
- $99,000
Chemoreflex control of breathing and the circulation
NSERC · 2021 · Principal investigator
- $12,500
Chemoreflex control of breathing and the circulation
NSERC · 2021 · Principal investigator
No publications available.
The use of semaglutide and resistance exercise to combat cognitive decline in older adults with Type 2 Diabetes: A combined pharmacological and lifestyle intervention
Principal investigators: Nagamatsu, Lindsay S; Reichert, Sonja M
Keywords: Rct; Resistance Exercise; Semaglutide; Type 2 Diabetes
Chemoreflex control of breathing and the circulation
Principal investigators: Keir, Daniel
Chemoreflex control of breathing and the circulation
Principal investigators: Keir, Daniel
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.